@teijisw.bsky.social
📤 0
📥 2
📝 3
Behind the Paper:
communities.springernature.com/posts/mrna-e...
loading . . .
mRNA-Encoded "Mini-Antibodies": A Next-Generation Shield Against Multidrug-Resistant Bacteria
Leveraging COVID-19 vaccine technology, we developed an mRNA-based mini-antibody therapy to neutralize multidrug-resistant P. aeruginosa. This rapid, cost-effective platform bypasses traditional manufacturing constraints and has shown dramatic efficacy in animal models.
https://communities.springernature.com/posts/mrna-encoded-mini-antibodies-a-next-generation-shield-against-multidrug-resistant-bacteria
about 1 month ago
0
0
0
Our paper on developing scFv mRNA therapy for Pseudomonas aeruginosa was just published in Nature Communications!
loading . . .
https://www.nature.com/articles/s41467-026-71040-8?utm_campaign=related_content&utm_source=HEALTH&utm_medium=communities
about 1 month ago
0
1
2
研究グループのメンバー大学院生の川口顕先生が，京都府立医科大学学友会の令和7年度青蓮賞（将来性のある有能な若手研究者の研究を奨励）を受賞．受賞論文：Highly pure mRNA vaccine provides robust immunization against P. aeruginosa by minimizing type I interferon responses.
www.sciencedirect.com/science/arti...
2 months ago
0
0
0
you reached the end!!
feeds!
log in
